Avenue Therapeutics (ATXI) Stock Chart & Stock Price History $0.34 +0.08 (+31.80%) As of 07/3/2025 11:23 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Avenue Therapeutics Stock Price Performance The Avenue Therapeutics (ATXI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 89.97%, with a year-to-date return of -83.01%. In the past month, the stock has increased 30.73%, reflecting recent market activity. As of the latest close, Avenue Therapeutics traded at $0.34 with a market cap of $1.08 million and volume of 357 shares. Five years ago, the stock traded at a split-adjusted price of $11,812.50, representing a 100.00% decrease over that period. At the time, it had a market cap of $179.67 million and a volume of 1,207 shares. Receive ATXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+41.39%1 Month Performance+30.73%3 Month Performance+30.63%Year-To-Date Performance-83.01%1 Year Performance-89.97%5 Year Performance-100.00% ATXI Stock Chart for Friday, July, 4, 2025 ATXI Chart by TradingView Avenue Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$0.26$0.34+31.80%$0.34$0.34357 shs$1.08 million07/02/2025$0.35$0.26-26.31%$0.34$0.261,043 shs$821,000.0007/01/2025$0.20$0.35+74.39%$0.38$0.2828,638 shs$1.11 million06/30/2025$0.24$0.20-16.51%$0.20$0.20305 shs$639,000.0006/27/2025$0.24$0.24$0.24$0.24606 shs$765,000.0006/26/2025$0.24$0.24-0.08%$0.28$0.24457 shs$765,000.0006/25/2025$0.24$0.24+0.04%$0.24$0.243,273 shs$766,000.0006/24/2025$0.24$0.24+0.17%$0.38$0.2414,118 shs$766,000.0006/23/2025$0.30$0.24-19.65%$0.28$0.223,170 shs$764,000.0006/20/2025$0.26$0.30+15.14%$0.34$0.2435,239 shs$951,000.00 Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$0.26$0.26$0.26$0.2667 shs$826,000.0006/18/2025$0.26$0.26$0.28$0.228,143 shs$826,000.0006/17/2025$0.22$0.26+20.64%$0.28$0.228,143 shs$826,000.0006/16/2025$0.21$0.22+3.31%$0.22$0.222,145 shs$685,000.0006/13/2025$0.28$0.21-26.59%$0.24$0.202,392 shs$663,000.0006/12/2025$0.22$0.28+31.60%$0.28$0.205,490 shs$903,000.0006/11/2025$0.26$0.22-17.12%$0.26$0.224,115 shs$686,000.0006/10/2025$0.20$0.26+29.55%$0.26$0.203,676 shs$828,000.0006/09/2025$0.26$0.20-22.81%$0.26$0.2011,327 shs$639,000.0006/06/2025$0.25$0.26+4.00%$0.26$0.20899 shs$828,000.0006/05/2025$0.26$0.25-3.85%$0.25$0.25234 shs$796,000.0006/04/2025$0.26$0.26$0.26$0.26219 shs$828,000.0006/03/2025$0.25$0.26+4.00%$0.26$0.202,006 shs$828,000.00 Related Companies Jaguar Animal Health Stock Price Chart Virax Biolabs Group Stock Price Chart Palatin Technologies Stock Price Chart Aspira Women's Health Stock Price Chart Aptevo Therapeutics Stock Price Chart Heatwurx Stock Price Chart Alzamend Neuro Stock Price Chart Conduit Pharmaceuticals Stock Price Chart Scinai Immunotherapeutics Stock Price Chart PowerUp Acquisition Stock Price Chart Receive ATXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATXI) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATXI Stock Alerts